Convulsive status epilepticus as a possible symptom of COVID-19 in a patient with intellectual disability and autistic spectrum disorder

Neurologia (Engl Ed). 2020 Nov-Dec;35(9):703-705. doi: 10.1016/j.nrl.2020.07.010. Epub 2020 Jul 31.
[Article in English, Spanish]
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adult
  • Autism Spectrum Disorder / physiopathology
  • Autism Spectrum Disorder / virology*
  • Azithromycin / therapeutic use
  • COVID-19 / complications*
  • COVID-19 / diagnosis
  • COVID-19 / physiopathology
  • COVID-19 Drug Treatment
  • Heparin, Low-Molecular-Weight / therapeutic use
  • Humans
  • Hydroxychloroquine / therapeutic use
  • Intellectual Disability
  • Male
  • Methylprednisolone / therapeutic use
  • Pandemics
  • SARS-CoV-2 / drug effects
  • Status Epilepticus / physiopathology
  • Status Epilepticus / virology*

Substances

  • Heparin, Low-Molecular-Weight
  • Hydroxychloroquine
  • Azithromycin
  • bemiparin
  • Methylprednisolone